Glenmark gets USFDA nod for Saxagliptin tablets
Glenmark has received tentative nod from the US health regulator for Saxagliptin tablets. Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted tentative approval by the United States... Press Release
Sub:- Glenmark Pharmaceuticals receives tentative ANDA approval for Saxagliptin Tablets, 2.5 mg and 5 mg With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Stocks that can give 20-40% returns from current levels
Glenmark stock has corrected 26% in the past one month due to the poor March quarter results. Glenmark gets USFDA nod for ADHD drug
Glenmark Pharmaceuticals has received final approval from the US health regulator for generic version of Strattera capsules, used in the treatment of attention-deficit/hyperactivity disorder (ADHD). Press Release
Dear Sirs, Sub:- Glenmark Pharmaceuticals receives ANDA approval for Atomoxetine Capsules USP, 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Glenmark receives US FDA approval for hypertension drug nebivolol
It is also eligible for 180 days exclusivity for the drug, a generic version of Forest's Bystolic Press Release
Dear Sirs, Sub:- Glenmark Pharmaceuticals receives ANDA approval for Nebivolol Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Glenmark gets USFDA's approval to sell generic blood pressure medicine
Glenmark's tablets will be manufactured by company's manufacturing facility located in Goa Press Release
Sub:- Glenmark Pharmaceuticals receives ANDA approval forOlmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mgWith reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Credit Rating
Sub:- Clarification relating to S&P; Global Rating Glenmark would like to clarify that S&P; Global Ratings has reaffirmed our credit rating as BB' as part of their annual review cycle. In addition, they have affirmed 'BB' issue rating on the senior unsecured notes issued last year. However, they have changed the outlook from Stable' to Negative', based on their internally defined criteria. Kindly find enclosed rating research update issued by S&P; Global for your reference.